Oregon lawmakers to vote on universal healthcare, lower drug prices

Oregon lawmakers are taking another pass at universal healthcare for the residents of state, according to a new report by The Register Guard. If SB 770 is passed, it will create a committee that would “design, implement and run a state health insurance plan.” 

Oregon is not the only state in the union to push for universal healthcare. A legislative committee in California heard proposals about how to achieve the goal of universal healthcare in the state. 

More than 35 state-level legislators are sponsors of the bill, which will allow residents who work full-time in Oregon to pay income tax, while simultaneously buying into the program. Financing of the program would come from a reserve held separately from the state’s general fund.

“This is just one step on the way to offering affordable healthcare to all Oregonians,” state Rep. Julie Fahey (D-Eugene), a chief co-sponsor of the bill, told The Register Guard.

Another high-profile bill the state legislature will vote on is SB 409—which will create a state committee to import drugs from Canada and offer them at a lower price to state pharmacies. The pharmacies will then pass those savings on to patients.

“I think that everyone believes that prescription drug prices are a huge problem,” said state Sen. Elizabeth Steiner Hayward (D-Portland).

To read the story, click the link below.

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.